Glykos Finland Oy
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Jun 2032
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 15, 2027The maintenance fee for Conjugates of a glycoprotein or a glycan with a toxic payload (US 11,723,983) comes due Feb 15, 2027. Unpaid by Aug 16, 2027, it lapses early.
- 2 fees due Apr 8 to 24, 2027 · next Apr 8
- 1 fee due May 28, 2027The maintenance fee for Protease Deficient Filamentous Fungal Cells and Methods of Use Thereof (US 11,827,891) comes due May 28, 2027. Unpaid by Nov 29, 2027, it lapses early.
- 1 fee due Jun 24, 2027The maintenance fee for Production of glycoproteins with mammalian-like N-glycans in filamentous fungi (US 10,513,724) comes due Jun 24, 2027. Unpaid by Dec 27, 2027, it lapses early.
- 1 fee due Jul 28, 2027The maintenance fee for Multiple Protease Deficient Filamentous Fungal Cells and Methods of Use Thereof (US 10,544,440) comes due Jul 28, 2027. Unpaid by Jan 28, 2028, it lapses early.
Recent changes
- 1 term has ended since Aug 23, 2026
- Oct 6 US 8,697,061 Tumor specific oligosaccharide epitopes and use thereof · term ended
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,399,764 | Fusion enzymes In force · USPTO record | In force | USPTO record | |
| US 10,731,168 | Protease Deficient Filamentous Fungal Cells and Methods of Use Thereof In force · Medium confidence | In force | Medium confidence | |
| US 11,180,767 | Protease Deficient Filamentous Fungal Cells and Methods of Use Thereof In force · Medium confidence | In force | Medium confidence | |
| US 11,827,891 | Protease Deficient Filamentous Fungal Cells and Methods of Use Thereof In force · Low confidence | In force | Low confidence | |
| US 9,567,596 | Protease deficient filamentous fungal cells and methods of use thereof In force · USPTO record | In force | USPTO record | |
| US 10,973,922 | Glycoprotein-toxic payload conjugates In force · USPTO record | In force | USPTO record | |
| US 11,723,983 | Conjugates of a glycoprotein or a glycan with a toxic payload In force · USPTO record | In force | USPTO record | |
| US 10,724,013 | O-Mannosyltransferase Deficient Filamentous Fungal Cells and Methods of Use Thereof In force · Medium confidence | In force | Medium confidence | |
| US 10,544,440 | Multiple Protease Deficient Filamentous Fungal Cells and Methods of Use Thereof In force · Medium confidence | In force | Medium confidence | |
| US 10,724,063 | Multiple Proteases Deficient Filamentous Fungal Cells and Methods of Use Thereof In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 15: 2 patents in force now held by others · 16 lapsed for an unpaid fee · 1 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending · 5 abandoned · 34 no status recorded